Published online Mar 7, 2018. doi: 10.3748/wjg.v24.i9.992
Peer-review started: November 10, 2017
First decision: December 13, 2017
Revised: December 22, 2017
Accepted: January 1, 2018
Article in press: January 1, 2018
Published online: March 7, 2018
Processing time: 116 Days and 1.2 Hours
Non-alcoholic fatty liver disease (NAFLD), as the leading cause of chronic liver disease, can result in serious liver-related complications and an increase in overall mortality. However, the pathogenesis of NAFLD is still unknown and no effective therapeutic strategy has been accepted as the standard treatment option. In previous studies, the authors found that JZG had beneficial effects in improving hepatic fat accumulation, metabolic disorder and associated liver injury, and its efficacy in patients with NAFLD was also confirmed.
Autophagy is important in liver diseases, and research has demonstrated that autophagy regulators can improve hepatic function. However, no effective therapeutic strategy has been accepted as the standard option for NAFLD and its complications. Thus, novel treatments are still urgently needed to prevent or delay the onset as well as the progression of NAFLD.
NAFLD, as the leading cause of chronic liver disease, could result in serious liver-related complications and an increase in overall mortality. And traditional Chinese medicine, as an alternative and complementary medicine, may be an effective addition to the current standardized intervention strategy.
The process of autophagy was detected by the expressions of LC3 and SQSTM1/p62. The upstream event of autophagy induction was presented by LC3-II/actin expression and the downstream event of autophagic flux was presented by the expressions of LC3-II/LC3-I and SQSTM1/p62. Stable fluorescence-expressing cell lines were established with mRFP-GFP-LC3 and mCherry-p62 lentivirus to visualize the whole progression of autophagic flux.
In previous research, the authors had demonstrated that the Chinese herbal formula JZG had beneficial effects in improving hepatic fat accumulation. In this study, autophagy was demonstrated to be critically involved in this process.
The authors confirmed that metabolic stress-induced hepatocyte injury exhibited dual effects on autophagy, while JZG activated the whole process to provide beneficial effects in NAFLD.
The exact compounds contained in this prescription are still unknown and the complex compounds might have led to multitarget effects. A systems pharmacology approach to determine the active compounds and action mechanisms might be a good method for the future research.